(Q34114308)

31 July 2017

Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors (English)

1 reference

31 July 2017

Sarah Knox

1

1 reference

31 July 2017

Catherine Merry

2

1 reference

31 July 2017

Sally Stringer

3

1 reference

31 July 2017

James Melrose

4

1 reference

31 July 2017

John Whitelock

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

14 February 2002

1 reference

Journal of Biological Chemistry

31 July 2017

1 reference

31 July 2017

277

1 reference

31 July 2017

14657-14665

1 reference

31 July 2017

17

1 reference

The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans

31 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Perlecan: a gem of a proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Perlecan is essential for cartilage and cephalic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Perlecan maintains the integrity of cartilage and some basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Examination of the substrate specificity of heparin and heparan sulfate lyases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Specificity studies on the heparin lyases from Flavobacterium heparinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Ligand binding properties of binary complexes of heparin and immunoglobulin-like modules of FGF receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Highly sensitive sequencing of the sulfated domains of heparan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Enzymatic degradation of glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Detection of secondary structure in glycosaminoglycans via the H n.m.r. signal of the acetamido NH group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Differential Regulation of FGF-1 and -2 Mitogenic Activity Is Related to Their Kinetics of Binding to Heparan Sulfate in MDA-MB-231 Human Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

Heparan Sulfate Proteoglycan Modulates Keratinocyte Growth Factor Signaling through Interaction with both Ligand and Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111826200

21 January 2018

Identifiers

DOI

10.1074/JBC.M111826200

0 references

1 reference